Address	3-5, impasse Reille Paris Ile-de-France 75014 France
Employees	-
Website	http://www.hybrigenics.com
Updated	07/08/2019
Hybrigenics SA operates as a biopharmaceutical company, which engages in the research and development of targets and therapies against proliferative diseases. It develops inecalcitol for the treatment of prostate cancer, chronic lymphocytic leukemia, and chronic myeloid leukemia. The company was founded on December 29, 1997 and is headquartered in Paris, France.